In human breast cancer cells, high levels of palladin expression are associated with increased invasiveness [15], [16], which suggests the possibility that abnormalities in palladin expression or function might contribute to the disregulated motility of metastatic cancer cells. This evidence concerns the gene PALLD and breast carcinoma.